Partners4Access Announces Membership with Health Technology Assessment international (HTAi)

LONDON - Aug. 22, 2024 - PRLog -- international (HTAi)

London, UK – 22^nd Aug 2024 – Partners4Access (P4A), a leading global consultancy specializing in orphan drugs, cell and gene therapies, market access, is proud to announce its membership with Health Technology Assessment international (HTAi). This prestigious organization is the global leader in advancing and promoting health technology assessment (HTA) to improve healthcare decision-making worldwide.

As a member of HTAi, Partners4Access joins a diverse network of international experts, policymakers, researchers, and industry leaders who are dedicated to the development and implementation of HTA. This membership aligns with P4A's mission to enhance patient access to innovative therapies by leveraging the latest advancements in HTA methodologies and best practices.

"We are thrilled to be part of HTAi, as it reinforces our commitment to being at the forefront of market access strategy and healthcare innovation," said Sophie Schmitz,  Managing Partner at Partners4Access. "This membership allows us to contribute to and benefit from a global exchange of knowledge and expertise, ultimately enhancing our ability to deliver tailored solutions that ensure life-changing therapies reach patients in need."

Partners4Access is committed to collaborating with HTAi's extensive network to further the application of HTA in the orphan drug and gene therapy space. Through this partnership, P4A aims to support the development of robust market access strategies that address the unique challenges of rare diseases, ensuring that patients around the world can benefit from the latest advancements in medical science.

About Partners4Access

Partners4Access (P4A) is a specialized global consultancy focused on providing market access, pricing, reimbursement and digital solutions for orphan drugs, cell and gene therapies, and other rare disease treatments. With a mission to improve patient access to life-changing therapies, P4A works closely with pharmaceutical and biotech companies to navigate the complex landscape of rare diseases, ensuring successful market entry and sustainable patient access.

For more information, visit www.partners4access.com.

About HTAi

Health Technology Assessment international (HTAi) is a global scientific and professional society for all those who produce, use, or encounter HTA in the healthcare field. HTAi members represent a variety of stakeholders, including academia, healthcare providers, government agencies, industry, and patient organizations, all dedicated to improving healthcare decision-making through the use of HTA.

For more information, visit www.htai.org.

Media Contact:

Georgie Rack
Head of Operations
Partners4Access
grack@partners4access.com